E
Iovance Biotherapeutics, Inc. IOVA
$2.45 -$0.08-3.16% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 11.43% 16.52% 16.18% 5.31% -5.10%
Total Depreciation and Amortization 13.57% 19.89% 31.63% 42.97% 65.09%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 55.49% 91.37% 76.49% 21.43% -7.41%
Change in Net Operating Assets -11.69% -310.19% -1,779.40% -371.82% -412.18%
Cash from Operations 21.95% 12.98% 2.44% -2.29% -16.02%
Capital Expenditure -71.76% 36.97% 50.34% 52.12% 40.19%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 100.00% 100.00% 75.28% 75.42% 73.42%
Divestitures -- -- -- -- --
Other Investing Activities 115.87% 132.85% -141.13% -185.24% -151.93%
Cash from Investing 102.05% 107.37% 37.90% -135.47% -415.21%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -61.52% -12.31% -13.36% -38.72% 23.04%
Repurchase of Common Stock -112.34% -147.91% -360.04% -366.23% -180.99%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -63.50% -14.55% -15.62% -40.34% 22.26%
Foreign Exchange rate Adjustments 220.87% 114.18% 80.26% 163.50% 110.93%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -57.66% 109.15% -4.26% -178.15% -133.71%